Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Christopher J. Edwards
Safety of Adalimumab Biosimilar MSB11022 (Acetate-Buffered Formulation) in Patients With Moderately-To-Severely Active Rheumatoid Arthritis
Clinical Rheumatology
Medicine
Rheumatology
Molecular Profile of Peripheral Blood Mononuclear Cells From Patients With Rheumatoid Arthritis
Molecular Medicine
Molecular Medicine
Genetics
Molecular Biology
Related publications
OP0021 Efficacy and Safety Results of a Phase Iii Study Comparing Fkb327, an Adalimumab Biosimilar, With the Adalimumab Reference Product in Patients With Active Rheumatoid Arthritis
AB0954 a Randomised, Double-Blind Trial Comparing the Efficacy, Safety and Immunogenicity of Msb11022, a Proposed Biosimilar of Adalimumab, Versus Adalimumab Originator in Patients With Moderate-To-Severe Plaque Psoriasis
Fri0087 Efficacy, Safety, and Immunogenicity Results of the Switch From Reference Adalimumab (Refadl) to Sandoz Biosimilar Adalimumab (Gp2017, SDZ-Adl) From Admyra Phase 3 Study in Patients With Moderate-To-Severe Rheumatoid Arthritis (Ra)
Adalimumab Discontinuation in Patients With Rheumatoid Arthritis After Achieving Sustained Remission
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Comparative Clinical Efficacy and Safety of the Proposed Biosimilar ABP 710 With Infliximab Reference Product in Patients With Rheumatoid Arthritis
Arthritis Research & Therapy
Rheumatoid Arthritis-Associated Uveitis Treated With Adalimumab
Klinika Oczna
Medicine
Ophthalmology
Long-Term Treatment of Rheumatoid Arthritis With Adalimumab
Open Access Rheumatology: Research and Reviews
Rheumatology
Adalimumab With or Without Methotrexate in Juvenile Rheumatoid Arthritis
New England Journal of Medicine
Medicine
Lethality of Patients With Rheumatoid Arthritis Depending on Adalimumab Administration: Imitation Modeling
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
